171 related articles for article (PubMed ID: 21940784)
1. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC;
Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784
[TBL] [Abstract][Full Text] [Related]
2. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
[TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung cancer.
Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
5. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
;
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
[TBL] [Abstract][Full Text] [Related]
6. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
7. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of crizotinib into the NCCN guidelines.
Riely GJ; Chaft JE; Ladanyi M; Kris MG
J Natl Compr Canc Netw; 2011 Dec; 9(12):1328-30. PubMed ID: 22157552
[No Abstract] [Full Text] [Related]
9. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ
Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
[TBL] [Abstract][Full Text] [Related]
11. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology.
Marchetti A; Ardizzoni A; Papotti M; Crinò L; Rossi G; Gridelli C; Barberis M; Maiorano E; Normanno N; Taddei GL; Scagliotti G; Clemente C; Pinto C
J Thorac Oncol; 2013 Mar; 8(3):352-8. PubMed ID: 23407559
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement.
Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A
Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621
[TBL] [Abstract][Full Text] [Related]
15. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
;
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):539-574. PubMed ID: 37460438
[TBL] [Abstract][Full Text] [Related]
16. Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium.
Allehebi A; Kattan KA; Rujaib MA; Dayel FA; Black E; Mahrous M; AlNassar M; Hussaini HA; Twairgi AA; Abdelhafeiz N; Omair AA; Shehri SA; Al-Shamsi HO; Jazieh AR
Cancer Treat Res Commun; 2022; 31():100538. PubMed ID: 35220069
[TBL] [Abstract][Full Text] [Related]
17. Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.
Wu YL; Planchard D; Lu S; Sun H; Yamamoto N; Kim DW; Tan DSW; Yang JC; Azrif M; Mitsudomi T; Park K; Soo RA; Chang JWC; Alip A; Peters S; Douillard JY
Ann Oncol; 2019 Feb; 30(2):171-210. PubMed ID: 30596843
[TBL] [Abstract][Full Text] [Related]
18. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; DeCamp MM; Dilling TJ; Dobelbower M; Doebele RC; Govindan R; Gubens MA; Hennon M; Horn L; Komaki R; Lackner RP; Lanuti M; Leal TA; Leisch LJ; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
J Natl Compr Canc Netw; 2017 Apr; 15(4):504-535. PubMed ID: 28404761
[TBL] [Abstract][Full Text] [Related]
19. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
Felip E; Gridelli C; Baas P; Rosell R; Stahel R;
Ann Oncol; 2011 Jul; 22(7):1507-1519. PubMed ID: 21536661
[TBL] [Abstract][Full Text] [Related]
20. Lung Cancer Treatment Advances in 2022.
Abu Rous F; Singhi EK; Sridhar A; Faisal MS; Desai A
Cancer Invest; 2023 Jan; 41(1):12-24. PubMed ID: 36036470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
